Sommadossi Jean-Pierre's Form 4 filing
Atea Pharmaceuticals, Inc. (AVIR) · filed Jun 7, 2024
- Accession no.
- 0000950170-24-070965
- Filed
- Jun 7, 2024
- Trade date
- Jun 5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $4.02K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sommadossi Jean-PierreCIK 0001296995 | Director, Officer (President, CEO, and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Common Stock | SSaleDisposed | −1,006 | $4.00 | −$4,024 | 5,923,994 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.